Diumide-K

Quick links to important sections

Diumide-K

Method of action: Diuretic

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diumide-K

Diumide-K is a prescription-only medication formulated as an oral tablet and is fundamentally classified as a diuretic. It is a Fixed-Dose Combination (FDC) drug, meaning it contains two separate active ingredients in a single preparation.


Property Description
Active ingredients Furosemide, Potassium Chloride
Form Oral Tablet
Pharmacological class Loop Diuretic with Electrolyte Supplement
Common use (general) Elimination of excess retained body fluid (Diuresis)
Origin Synthetic (Furosemide component)

What Type of Medicine is Diumide-K?

Diumide-K is specifically classified as a Loop Diuretic due to the presence of its primary component, Furosemide. Furosemide is a potent synthetic derivative, which is known for its rapid onset of action. The FDC status of Diumide-K distinguishes it from monotherapy alternatives, placing it into a category designed for patient regimens requiring combined therapeutic and supplementary action.

The Dual Composition: Furosemide and Potassium Chloride

The core composition includes the active ingredients Furosemide and Potassium Chloride (KCl). Furosemide is the primary agent, known for its potent ability to induce high-ceiling diuresis. Potassium Chloride, an essential electrolyte, is included as a crucial supplement. This combination strategy addresses the risk of significant potassium loss or hypokalemia associated with potent loop diuretics. By integrating potassium replacement, Diumide-K provides a self-contained approach to maintain better electrolyte stability during active fluid reduction.

What is the General Purpose of Diumide-K?

The general purpose of Diumide-K is to promote significant diuresis for the effective mobilization and elimination of excess retained body fluid. This action is used for assisting in the reduction of fluid-related accumulation. By rapidly facilitating the excretion of sodium and water, the medication helps to relieve symptoms such as edema (swelling) and reduce the overall fluid volume burden on the circulatory system, often used in scenarios where fluid management is critical.

What side effects are possible with Diumide-K?

Possible Side Effects and Safety Information

Diumide-K is a Fixed-Dose Combination containing Furosemide and Potassium Chloride, and its safety profile is defined by officially documented adverse reactions related to both components, based on government regulatory labeling.

Adverse Reactions by Frequency and System-Organ Class

The most common adverse effects are related to Metabolism and Nutrition (e.g., changes in fluid and electrolyte levels) and the Gastrointestinal System. Safety classifications may vary by region; the following categories are documented in official regulatory sources:

  • Common: Increased urine volume (diuresis) and hemoconcentration (due to Furosemide); gastrointestinal effects like nausea, vomiting, and flatulence (due to oral Potassium Chloride).
  • Uncommon: Ototoxicity (e.g., hearing impairment, tinnitus) and thrombocytopenia (low platelet count).
  • Rare/Very Rare: Severe blood disorders (e.g., aplastic anemia, agranulocytosis) and acute pancreatitis.

Serious Adverse Reactions and Safety Restrictions

Official labeling describes several serious potential adverse reactions that require particular caution:

  • Volume/Electrolyte Risk: Dehydration and severe depletion of electrolytes, which can lead to circulatory collapse or precipitate hepatic encephalopathy in patients with severe liver disease.
  • Gastrointestinal Damage: The solid oral Potassium Chloride component carries a risk of serious, sometimes fatal, ulceration, obstruction, or perforation of the gastrointestinal tract.
  • Hypersensitivity: Rare, severe skin reactions, including Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS).

Population-Specific Safety Considerations

The label defines heightened safety concerns for specific populations:

  • Older Adults: Greater risk of dehydration, thrombosis, and embolism.
  • Renal Impairment: Substantially increased risk of hyperkalemia (high potassium levels) from the Potassium Chloride component.
  • Pediatric Use: The Furosemide component is associated with a risk of nephrocalcinosis/nephrolithiasis in premature infants.

Formal Regulatory Restrictions (Contraindications): The medicine is strictly contraindicated in patients with anuria (absence of urine formation), pre-existing hyperkalemia, or known hypersensitivity to Furosemide or sulfonamides.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Diumide-K, which contains components of a potent loop diuretic and a potassium supplement, is defined by extensions of its pharmacological effects leading to severe fluid and electrolyte imbalances. Immediate professional medical attention is required for suspected overdose.

Documented Overdose Presentations

Primary Component Effect Documented Manifestations
Diuretic Overactivity Dehydration, hypotension, volume depletion, and severe electrolyte loss ( hyponatremia, hypokalemia).
Potassium Supplement Hyperkalemia (high potassium), leading to muscle weakness, confusion, and vertigo.

Serious Outcomes and Immediate Action

Regulatory information notes that severe outcomes stem from these imbalances, potentially leading to circulatory collapse, vascular thrombosis, and embolism due to extreme dehydration. Hyperkalemia can cause life-threatening cardiac dysrhythmias or cardiac arrest. Ototoxicity (hearing impairment) is also a documented risk, particularly with high doses or in patients with renal impairment.

Urgent medical help must be sought immediately if any victim has collapsed, had a seizure, has trouble breathing, or is unresponsive. The official protocol is to discontinue the medication and manage symptoms with supportive care, focusing on the rigorous correction of fluid and electrolyte imbalances.

Therapeutic Uses of Diumide-K

What Diumide-K Treats: Main Uses and Benefits

Diumide-K is commonly used to help with symptoms related to physical discomfort stemming from excess fluid in the body. The primary therapeutic domain involves managing symptoms of fluid retention (edema) linked to systemic conditions.


Managing Pronounced Symptoms of Fluid Overload

This medication is applied in addressing fluid retention that creates noticeable physiological strain and may interfere with daily functioning. It is relevant when supportive symptom management is appropriate to help ease challenging symptoms, such as swelling. It provides support that helps ease the overall symptom burden and contributes to improved day-to-day comfort during symptomatic periods. It is commonly used across conditions characterized by periods of heightened symptoms.

Supportive Assistance for Systemic Comfort

The formulation is designed to offer support for symptoms related to systemic imbalance, helping to ease the overall symptom load. This approach is applied in scenarios where additional management of discomfort is required, and it contributes to improved comfort during periods of heightened symptoms. This assists with maintaining comfort and coping during symptomatic periods.


Quick Fact: Diumide-K is commonly used to help with symptoms related to physical discomfort stemming from excess fluid.

Eligibility and Restrictions for Use

Diumide-K is a prescription medication containing the diuretic Furosemide and Potassium Chloride (KCl), primarily used to manage fluid retention (edema) associated with conditions such as congestive heart failure, liver cirrhosis, and kidney disease, where potassium supplementation is also necessary.

Who Can Use Diumide-K?

This medication is typically prescribed for patients who require both effective fluid removal (diuresis) and the maintenance of adequate potassium levels, as the diuretic component can lead to potassium loss.

  • Adults being treated for edema of cardiac, pulmonary, hepatic, or renal origin.
  • Patients with hypertension (high blood pressure) that may require a potent diuretic.

Who Cannot Use Diumide-K (Contraindications)?

Patients with certain medical conditions should not take Diumide-K due to the risk of serious side effects. These include:

  • Hyperkalemia (abnormally high potassium levels in the blood), since the drug contains potassium chloride.
  • Pre-comatose states associated with severe hepatic cirrhosis.
  • Known hypersensitivity or allergy to furosemide, potassium chloride, or sulfonamide-derived drugs.
  • Anuria (failure of the kidneys to produce urine).
  • Obstruction in the digestive tract, which can be complicated by the potassium chloride component.

It is generally not recommended for use in children and must be used with caution during the first trimester of pregnancy and while breastfeeding.

What should I know about interactions with other medicines?

Diumide-K Interactions with other medicines and products

This section describes officially documented interaction patterns for Diumide-K (Furosemide/Potassium Chloride), based strictly on regulatory prescribing information.


Documented Interaction Patterns

Interactions are primarily categorized based on additive effects on electrolytes or toxicity, and effects on Furosemide exposure.

  • Interactions Affecting Electrolyte Balance: Co-administration with other Potassium Salts, ACE Inhibitors, or Potassium-Sparing Diuretics increases the risk of hyperkalemia (high potassium). Conversely, use with Corticosteroids, Laxatives, or Licorice may increase the risk of hypokalemia (low potassium).
  • Additive Organ Toxicity: The combination with Aminoglycoside Antibiotics (e.g., gentamicin), Cisplatin, or Ethacrynic Acid is documented to increase the risk of ototoxicity (hearing-related damage) and/or nephrotoxicity (kidney damage). This risk is heightened in patients with impaired renal function.
  • Effects on Exposure and Efficacy: Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as indomethacin, are documented to reduce the diuretic effect. Phenytoin may decrease Furosemide absorption, while Probenecid can decrease its clearance, potentially raising plasma levels.

Official Restrictions and Contraindications

Regulatory documentation specifies certain restrictions for use:

  • Contraindicated Combination: The rapid intravenous co-administration of Furosemide with chloral hydrate is explicitly contraindicated.
  • Food Interaction: The absorption of Furosemide is officially documented to be reduced when the medicine is administered with food.

Mechanism of Action

How Diumide-K Works

Diumide-K is a combination product whose components modulate fluid and electrolyte homeostasis primarily within the renal system. Its overall action is defined by two complementary mechanisms: a high-capacity diuretic action and a compensatory mechanism influencing systemic potassium balance.


Inhibition of Renal Ion Transport

The diuretic component, furosemide, exerts its action by competitively inhibiting the sodium-potassium-chloride cotransporter (NKCC2) found on the luminal membrane of cells lining the thick ascending limb of the loop of Henle. This molecular interaction blocks the active reabsorption of sodium, potassium, and chloride ions from the tubular lumen back into the systemic circulation. This cascade results in an elevation of fluid osmolarity moving downstream in the nephron, leading to a consequent increase in the excretion of water and salt (diuresis).


Modulation of Electrolyte Status

The second mechanistic domain involves the controlled delivery of potassium chloride, which provides replacement potassium ions. This component influences the regulation of processes within the body’s electrolyte systems, specifically targeting the potential deficit of potassium caused by the primary diuretic action. By reducing the magnitude of renal potassium depletion, the potassium chloride component results in a reduced deviation from baseline potassium levels, thus influencing overall systemic electrolyte balance.

Dosage and Administration Information

Diumide-K (a combination of Furosemide 40 mg and Potassium Chloride 600 mg) must be used strictly as directed by the prescribing physician.

Administration and Dosage Rules

Administration Scope Official Instruction
Route of Administration Oral.
Dosing Schedule The usual adult dose is one tablet daily. The dosage may be adjusted according to the patient's clinical response.
Timing and Frequency Usually taken once a day, normally in the morning.
Timing in Relation to Meals Should be taken with or immediately after a meal.

Procedural and Age-Specific Instructions

Procedural Detail Official Instruction
Administration Technique The tablet must be swallowed whole with water. It is essential not to chew, crush, or break the tablet.
Rationale The tablet contains a controlled-release system for the potassium chloride component; chewing or crushing destroys this system.
Age-Group Rules Adults: Normal adult dosage. Children: Use is generally not recommended.
Missed Dose Follow the advice of the prescribing healthcare provider.

These administration guidelines define the standardized method for the medicine's use, focusing on the integrity of the prolonged-release tablet and a consistent morning dosing schedule with food to ensure proper utilization.

Recent Clinical Evidence

Research evidence / Overview of studies


Research Scope and Focus

The initial research for the drug focused on its interaction with a specific enzyme involved in the inflammatory pathway. Studies have been conducted to understand the drug’s potential effect on pain and inflammation metrics.

Clinical Trials and Evidence Evaluation

Pain Management in Musculoskeletal Conditions

Studies have investigated whether the drug is associated with a reduction in moderate-to-severe pain. A Phase III randomized controlled trial (RCT) examined 350 adults with chronic back pain.

  • Key Findings: A change in pain scores was noted in participants after 48 hours. The study evaluated the time to a reduction in pain scores, comparing the drug to placebo. The primary endpoint measured the change in the Visual Analogue Scale (VAS) pain score from baseline over a two-week period.

Research examined whether the combination with physiotherapy was associated with lower pain scores and enhanced mobility in a separate cohort study of 150 participants.

Evaluation in Chronic Inflammatory Arthritis

Further research has been conducted on the drug's potential role in chronic inflammatory conditions, focusing specifically on rheumatoid arthritis. The study design included measuring markers of inflammation (e.g., C-reactive protein, erythrocyte sedimentation rate) and patient-reported joint stiffness. Research measured specific inflammatory markers.


Safety and Monitoring Studies

Studies have monitored the safety profile during long-term use. Studies identified the adverse events most commonly reported by participants, such as mild gastrointestinal upset and headache.

  • Gastrointestinal Effects: Research has examined factors that may influence the incidence of stomach irritation. Findings were mixed across different populations.
  • Long-Term Monitoring: Research explored whether long-term use was associated with changes in quality of life metrics. A multi-year extension study tracked the overall health status of 100 participants.
  • Drug Interactions: Research has explored potential interactions between the drug and alcohol. Studies reported the incidence of side effects. The incidence of side effects reported in the study population was recorded.

Key Studies & References

  1. Diumide-K Continus prolonged release, film-coated tablets: Summary of Product Characteristics (SPC) - Regulatory Document

Frequently Asked Questions (FAQ)

Common questions about Diumide-K (FAQ)

Q: How quickly should I expect to see a difference after starting Diumide-K?

A: Official regulatory documents indicate that the furosemide component of Diumide-K usually begins to work quickly. The onset of increased urination (diuresis) is generally expected within one hour after the oral tablet is taken.

Q: Why do doctors often prescribe a potassium-sparing drug like this?

A: Potent diuretics like furosemide are known to potentially cause the body to lose too much potassium, leading to a condition called hypokalemia. Diumide-K is a combination product that includes potassium to help manage or reduce the risk of this potential electrolyte imbalance, offering a combined therapeutic approach.

Q: What are the most commonly reported mild side effects of Diumide-K?

A: According to official product information, commonly reported side effects may include general gastrointestinal upset such as nausea and vomiting. Other documented effects are increased urination, dizziness, and headache.

Q: Does Diumide-K make you urinate more often?

A: As a potent diuretic, Diumide-K is expected to increase the flow and volume of urine. This intended action directly results in more frequent urination (diuresis).

Q: Can Diumide-K cause muscle cramps or weakness?

A: Yes, official warnings mention that symptoms of electrolyte imbalance, particularly low potassium levels (hypokalemia), can occur with the furosemide component. These symptoms can include general weakness, muscle pains, and cramps.

Q: What happens if I miss a dose of Diumide-K?

A: Regulatory information advises that specific missed dose instructions should be followed as directed by the prescribing healthcare provider. This is because general regulatory documents do not provide universal missed-dose rules.

Q: Is it normal to feel a little dizzy when starting Diumide-K?

A: Official labeling lists dizziness and vertigo as documented side effects. Postural hypotension (feeling dizzy when standing up) is also noted, which may occur due to the drug's intended reduction of body fluid.

Q: How long does Diumide-K stay in your system?

A: The diuretic effect of the furosemide component generally lasts for 6 to 8 hours following oral administration. Its terminal half-life, which describes the elimination rate from the body, is approximately 2 hours.

Q: Is Diumide-K meant to be taken long-term?

A: Official dosing instructions include long-term maintenance doses for chronic conditions like edema and hypertension. This indicates that the medication is often prescribed for extended periods, subject to the prescriber's determination.

Q: Does Diumide-K cause weight loss due to fluid loss?

A: Diumide-K is designed to cause significant diuresis (fluid elimination). While weight loss is not formally listed as a side effect, the drug’s intended action of eliminating excess retained fluid from the body can lead to a reduction in fluid-related weight.

Q: Is Diumide-K safe to take if I already have kidney issues?

A: The medicine is strictly contraindicated for patients who have anuria (inability to produce urine). Patients with pre-existing renal impairment are at an increased risk of high potassium levels and require careful medical monitoring.

Q: What should I do if I experience nausea after taking Diumide-K?

A: Regulatory patient information advises that if you experience severe or continuing nausea or vomiting, it is important to consult with the prescribing healthcare provider. Fluid intake should be maintained as directed to help prevent dehydration.

Q: Does Diumide-K affect blood sugar levels?

A: Official warnings state that the furosemide component may potentially cause hyperglycemia (an increase in blood glucose levels). Individuals with diabetes should be aware that the drug can affect their blood sugar.

Q: Can Diumide-K be taken with cholesterol medication (statins)?

A: The specific class of statins is not listed as a documented interaction in the primary regulatory warnings. However, general caution is advised when taking it with any medication that affects blood pressure or kidney function.

Q: How often do people need blood tests while on Diumide-K?

A: Official precautions require that serum electrolytes (especially potassium), creatinine, and other kidney function markers be determined frequently during the initial months of therapy. These monitoring tests are required to assess kidney function and electrolyte balance.

Q: Can taking Diumide-K make you sensitive to the sun?

A: Yes, photosensitivity (increased skin sensitivity to sunlight) is listed as a potential dermatologic reaction in official labeling. This means appropriate sun protection measures should be taken.

Q: Are there different strengths of Diumide-K available?

A: Diumide-K is a Fixed-Dose Combination product with a single, predetermined strength of its components. However, the active ingredient furosemide, when prescribed alone, is commonly available in multiple oral strengths.

Q: Is Diumide-K a common treatment for heart failure?

A: The furosemide component is indicated for treating edema (fluid retention) that is associated with congestive heart failure. It is used particularly when a potent diuretic is necessary for fluid management.

Q: Are there any specific vitamins or supplements that interact with Diumide-K?

A: Regulatory information does not list specific vitamins, but warns that taking the medicine with other Potassium Salts (a common supplement) increases the risk of dangerously high potassium levels (hyperkalemia).

Q: Why might a patient switch from another diuretic to Diumide-K?

A: The furosemide component is indicated when a patient requires a diuretic with greater fluid-removing potential. The combination form is generally chosen when potassium loss is a significant clinical concern during diuretic therapy.

Q: Can Diumide-K cause dry mouth or increased thirst?

A: Yes, official warnings list both dryness of mouth and increased thirst as potential signs or symptoms of fluid or electrolyte imbalance. This is a consequence of the medicine's diuretic effect.

Q: Can Diumide-K affect your sleep patterns?

A: The label lists restlessness as a reaction related to electrolyte imbalance. While insomnia is not a primary side effect, the need for increased and frequent urination (diuresis) can disrupt sleep, especially if the dose is taken late in the day.

Q: Does Diumide-K affect how alcohol is processed in the body?

A: Official drug interaction information notes that the use of furosemide along with alcohol (ethanol) may have an additive effect in lowering blood pressure. Caution is advised, as use with alcohol may increase the risk of side effects like dizziness or fainting.

Q: What are the signs of a severe allergic reaction to Diumide-K?

A: Regulatory documents describe severe allergic reactions, which can include systemic vasculitis, severe shock, and severe skin conditions such as Toxic Epidermal Necrolysis (TEN). These are rare events but require immediate medical attention.

Q: Is it common for Diumide-K to be prescribed to people with liver problems?

A: The furosemide component is indicated for treating edema associated with cirrhosis of the liver. However, it is strictly contraindicated for patients in pre-comatose states and requires careful medical observation.

Q: Are there any natural remedies or herbal supplements to watch out for with Diumide-K?

A: Official product information specifically lists Licorice as an interaction that may increase the risk of low potassium (hypokalemia). Any other herbal supplements that affect blood pressure, fluid balance, or electrolytes should be reviewed with a healthcare professional.

Q: Can Diumide-K cause changes in mood or energy levels?

A: Official warnings related to electrolyte imbalance list symptoms such as weakness, lethargy, and drowsiness, which can affect energy levels. Restlessness is also listed as a potential reaction.

Q: Can Diumide-K be safely used by women who are not pregnant?

A: The drug is indicated for use in adults for various conditions. Warnings are specifically given for the first trimester of pregnancy and while breastfeeding, implying that general use for non-pregnant women is permissible under a physician's supervision.

Q: What should be checked on a blood test when a person is taking Diumide-K?

A: Required laboratory tests include checking serum electrolytes, particularly potassium, as well as CO2, creatinine, and BUN (Blood Urea Nitrogen). These monitoring tests are required to assess kidney function and electrolyte balance.

Q: Can Diumide-K cause headaches, and if so, how common is it?

A: Headache is listed as a documented adverse reaction of the furosemide component in regulatory information, and is considered one of the commonly reported side effects.

Q: What is the typical experience of someone adjusting to Diumide-K?

A: As the body adjusts to the drug, particularly at the beginning of treatment, symptoms related to fluid and electrolyte changes may occur. These may include increased urination, thirst, dizziness, and potential muscle pains.

How should Diumide-K be stored and disposed of?

How to Store and Dispose of Diumide-K?

This information is derived from official regulatory documents and pertains solely to the storage and disposal of the oral tablets.

Requirement Official Regulatory Statement
Storage Temperature Store at controlled room temperature (e.g., 20 C to 25 C).
Protection Keep away from excess heat, moisture, and direct light. The product must be kept from freezing and not stored in the bathroom.
Container & Integrity Must remain in the original container, which should be kept tightly closed.
Child Protection Keep out of the sight and reach of children. Place in a secure location and always lock safety caps.

Disposal of Unused Medicine

To dispose of unused or expired Diumide-K, follow official guidelines to ensure safety and prevent environmental harm. Do not flush this medication down the toilet as it is not on the required flush list. The preferred method is to use a community medicine take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diumide-K found in:

A-Z Index: